🇺🇸 UTHR — United Therapeutics Corporation
Salud CompraPrecio actual
562,02 USD
Máx. histórico
608,49
2 días
Split 2:1 del 23/09/2009
Caída desde máximo
-7,64%
Rango 52 semanas
444,04 – 614,23
Variación hoy
-0,65%
Cierre anterior
565,72
Rango de hoy
559,41 – 569,45
Volumen hoy
454.934
Peor caída histórica
-93,18%
12/07/2000 → 10/12/2001
Recuperado en 3311 días
Volatilidad anualizada ⓘ
46,96%
- Nombre completo
- United Therapeutics Corporation
- Divisa
- USD
- Mercado
- NasdaqGS
- Sector
- Salud
- Industria
- Drug Manufacturers - Specialty & Generic
- Empleados
- 1.400
- PER ⓘ
- 21,22 (puede no estar actualizado)
- Dividend yield
- 0,00% (puede no estar actualizado)
- Precio objetivo analistas
- 670,93 USD (puede no estar actualizado)
- Primera cotización
- 17/06/1999
- Precio actualizado
- hace 2 horas
United Therapeutics Corporation engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. It offers Tyvaso DPI, an inhaled dry powder via pre-filled and single-use cartridges; Nebulized Tyvaso, an inhaled solution via ultrasonic nebulizer; Remodulin (treprostinil) injection to treat patients with pulmonary arterial hypertension to diminish symptoms associated with exercise; Orenitram, a tablet dosage form of treprostinil, to delay disease progression and improve exercise capacity in PAH patients; and Adcirca, an oral PDE-5 inhibitor to enhance the exercise ability in PAH patients. It also markets and sells Unituxin (dinutuximab) injection, a monoclonal antibody for high-risk neuroblastoma; and Remunity Pump, which contains a pump and separate controller for Remodulin. In addition, it is involved in developing RemunityPRO Pump and Ralinepag for the treatment of PAH;and Nebulized Tyvaso, for the treatment of idiopathic pulmonary fibrosis, as well as xenografts, which are development-stage organ products. Further, it provides preclinical products, including EVLP/CLES, for lung transplant; UKidney, UHeart, UThymoKidney, a development-stage gene-edited porcine kidneys and hearts for xenotransplantation; ULobe, for allogeneic regenerative medicine; ULung, for autologous regenerative medicine; IVIVA Kidney, for autologous regenerative medicine; miroliver, for allogeneic regenerative medicine; and mirokidney, for allogeneic regenerative medicine. It has licensing and collaboration agreements with DEKA Research & Development Corp. to develop a semi-disposable system for the subcutaneous delivery of treprostinil; MannKind Corporation to develop and license treprostinil inhalation powder and the Dreamboat device; and Arena Pharmaceuticals, Inc. to develop Ralinepag. The company was founded in 1996 and is headquartered in Silver Spring, Maryland.
| Fecha | Ratio |
|---|---|
| 23/09/2009 | 2:1 |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 08/08/2008 | 54,28 | 56,76 | 54,21 | 54,86 | +0,68% | 4,69% | 1.920.200 |
| 07/08/2008 | 56,26 | 57,18 | 54,44 | 54,49 | -3,47% | 4,88% | 1.348.200 |
| 06/08/2008 | 58,07 | 58,71 | 56,40 | 56,45 | -2,66% | 3,98% | 1.234.400 |
| 05/08/2008 | 55,79 | 58,31 | 55,58 | 57,99 | +1,96% | 4,88% | 1.703.200 |
| 04/08/2008 | 57,00 | 57,17 | 56,03 | 56,88 | -0,57% | 2,01% | 1.222.800 |
| 01/08/2008 | 57,03 | 58,05 | 56,28 | 57,20 | +0,89% | 3,11% | 1.585.000 |
| 31/07/2008 | 52,53 | 58,91 | 52,01 | 56,70 | +6,15% | 13,14% | 3.012.800 |
| 30/07/2008 | 52,86 | 55,00 | 52,86 | 53,41 | +1,94% | 4,06% | 1.439.400 |
| 29/07/2008 | 52,09 | 53,06 | 51,82 | 52,40 | +1,06% | 2,38% | 1.173.600 |
| 28/07/2008 | 52,35 | 53,44 | 51,50 | 51,85 | -1,21% | 3,71% | 645.000 |
| 25/07/2008 | 52,50 | 53,06 | 52,09 | 52,48 | +0,00% | 1,84% | 866.400 |
| 24/07/2008 | 52,82 | 53,23 | 52,23 | 52,48 | -0,17% | 1,90% | 447.800 |
| 23/07/2008 | 52,55 | 52,79 | 52,15 | 52,57 | +0,04% | 1,22% | 676.400 |
| 22/07/2008 | 52,50 | 53,25 | 52,18 | 52,55 | -0,81% | 2,04% | 1.236.000 |
| 21/07/2008 | 53,70 | 53,70 | 52,54 | 52,98 | -0,01% | 2,16% | 1.348.600 |
| 18/07/2008 | 53,97 | 54,10 | 52,83 | 52,99 | -1,51% | 2,35% | 589.600 |
| 17/07/2008 | 52,90 | 54,99 | 52,39 | 53,80 | +2,10% | 4,92% | 1.370.800 |
| 16/07/2008 | 52,83 | 53,03 | 52,00 | 52,70 | -0,06% | 1,94% | 1.059.000 |
| 15/07/2008 | 49,50 | 53,19 | 49,38 | 52,73 | +6,12% | 7,69% | 1.726.200 |
| 14/07/2008 | 50,58 | 50,58 | 49,09 | 49,69 | -0,86% | 2,94% | 1.000.800 |
| 11/07/2008 | 50,76 | 51,18 | 49,51 | 50,12 | -1,96% | 3,30% | 884.600 |
| 10/07/2008 | 49,99 | 51,50 | 49,60 | 51,12 | +2,32% | 3,79% | 952.400 |
| 09/07/2008 | 49,61 | 51,28 | 49,50 | 49,96 | -0,14% | 3,58% | 1.821.400 |
| 08/07/2008 | 50,07 | 50,35 | 49,30 | 50,03 | +0,36% | 2,10% | 1.171.400 |
| 07/07/2008 | 50,30 | 50,80 | 49,27 | 49,85 | -2,93% | 3,03% | 1.402.200 |
| 03/07/2008 | 52,85 | 53,12 | 51,05 | 51,35 | -2,80% | 3,92% | 696.800 |
| 02/07/2008 | 51,62 | 53,38 | 51,18 | 52,83 | +2,63% | 4,26% | 2.597.400 |
| 01/07/2008 | 48,26 | 51,48 | 48,18 | 51,48 | +5,32% | 6,84% | 1.765.200 |
| 30/06/2008 | 48,15 | 49,22 | 48,06 | 48,88 | +1,36% | 2,41% | 827.000 |
| 27/06/2008 | 47,01 | 48,48 | 46,46 | 48,22 | +2,75% | 4,30% | 1.274.200 |